BEECHES CORPORATE LTD

Company number SC669898 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BEECHES CORPORATE LTD - Analysis Report

Company Number: SC669898

Analysis Date: 2025-07-19 12:44 UTC

Financial Health Assessment: BEECHES CORPORATE LTD


1. Financial Health Score: Grade D

Explanation:
The company’s financial health shows significant signs of distress in the latest year (2023). While previous years (2020-2022) reflected a robust and healthy position with strong working capital and shareholders’ funds, 2023 exhibits a drastic deterioration with net current assets barely positive (£104) and current liabilities almost matching current assets (£118,550 vs £118,654). This near-zero working capital and equity erosion are symptoms of financial strain, suggesting liquidity challenges and potentially impaired operational stability.


2. Key Vital Signs

Metric 2023 (£) 2022 (£) Interpretation
Current Assets 118,654 120,523 Stable total assets but composition shifted
Cash at bank 3,188 119,756 Severe cash depletion; alarm signal
Debtors 115,466 767 Large increase in receivables; potential collection risk
Current Liabilities 118,550 26,750 Sharp increase; pressure on short-term obligations
Net Current Assets (Working Capital) 104 93,773 Collapsed from healthy buffer to near zero
Shareholders' Funds (Equity) 104 93,773 Virtually wiped out; loss of net worth

Interpretation of Vital Signs:

  • Healthy cash flow is absent; cash reserves plunged from £119k to just over £3k, a critical symptom of liquidity distress.
  • Debtors ballooned to £115k, largely from related party transactions, which may indicate delayed cash inflows and risk of bad debts.
  • Current liabilities surged, suggesting the company is facing increased short-term financial obligations, possibly overdue payables or accrued expenses.
  • Net current assets and equity are critically low, signaling the company’s buffer to meet immediate debts is almost nonexistent, posing a risk to solvency.

3. Diagnosis

The financial “symptoms” point to a company in a precarious condition:

  • The sharp increase in related party debtors (£115k) in 2023, compared to negligible in 2022, introduces uncertainty around cash recovery, potentially masking underlying operational cash shortages.
  • The drastic reduction in cash holdings is a red flag indicating the company may be relying on credit or delayed payments to sustain operations—akin to a patient running out of vital fluids.
  • The near elimination of net assets and shareholders’ funds suggests accumulated losses or write-downs that have eroded equity, weakening the company’s financial resilience.
  • The company still reports a positive but minimal net current assets figure (£104), which is insufficient as a safety margin, implying a fragile financial state and vulnerability to any unforeseen expenses or delays in cash collections.

Overall, these data indicate the company is experiencing acute financial stress, with liquidity problems and possible solvency risks if conditions persist or worsen.


4. Recommendations

To restore financial wellness and stabilize the company’s condition, I advise the following steps:

  1. Urgently improve cash flow management:

    • Expedite collection of the large related party debtor balance or convert it into equity or long-term receivable to relieve liquidity pressure.
    • Review credit terms and tighten debtor controls to avoid cash flow bottlenecks.
  2. Review and restructure current liabilities:

    • Negotiate extended payment terms with creditors to reduce immediate cash outflow demands.
    • Prioritize payments to avoid penalties or supplier relationship damage.
  3. Assess operational profitability and cost structure:

    • Conduct a thorough review of expenses and revenue streams to identify loss-making areas.
    • Implement cost control measures to prevent further equity erosion.
  4. Consider capital injection or refinancing options:

    • Explore additional funding from shareholders or external lenders to strengthen the capital base and provide liquidity.
    • Evaluate the feasibility of debt restructuring or equity financing to improve solvency.
  5. Enhance financial monitoring:

    • Institute regular cash flow forecasting and financial health checks to detect early warning signs and take proactive action.

Medical Analogy Summary

Beeches Corporate Ltd’s financial health resembles a patient whose vital signs were stable in past years but now shows symptoms of acute distress: depleted cash reserves (fluid loss), swollen debtors (blockage in circulation), and dangerously low equity (loss of strength). Immediate intervention is necessary to stabilize liquidity and restore financial vitality, or the risk of financial collapse (insolvency) will increase.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.